With the critical success and recognition of I Am Shelby Lynne, she was awarded the Best New Artist GRAMMY® in 2000 – after nearly 13 years in the business. Love, Shelby was released in 2001, followed by a pair of intimate, self-produced albums – Identity Crisis (2003) and Suit Yourself (2005). She made her acting debut in 2005, playing Johnny Cash's mother in the Fox Searchlight motion picture Walk the Line. Just a Little Lovin’, her critically acclaimed tribute to Dusty Springfield, was released in 2008.
Never one to go with the crowd, Shelby continues to stand apart from the mainstream music world. She recently founded her own label, EVERSO RECORDS. Lynne’s Tears, Lies, And Alibis, EVERSO’s first release, debuted at No. 16 on Billboard’s Top Independent Albums chart in April of 2010. A Top 10 hit at Americana radio, it was hailed by Newsday as “her strongest album in a decade,” a sentiment echoed by numerous critics. She followed Tears, Lies, And Alibis with her first-ever holiday collection, Merry Christmas, released in the fall of 2010.
Revelation Road – Shelby’s most personal record yet – will be released on October 18, 2011. She wrote, recorded and produced the album, which leads off with the title track and first single, “Revelation Road,” a stirring reflection on reckoning and redemption. Lynne will be touring North American this fall.
Saxo Bank, the online trading and investment specialist, believes a reasonably positive economic momentum barring a geopolitical crisis is likely during Q2 2012. The eventual return of QE seems inevitable as central banks try to keep the crisis at bay and the compounding of policy errors failing to address the solvency problem and growing social and geo-political friction will potentially lead to an explosive outcome.
According to the Bank’s analysts, Europe will continue on the path of flat growth despite the Eurozone having entered recession at the tail-end of last year. However the rebound in economic growth in the US will eventually spill over into Europe, and Asia will continue to aid its growth through imports. If the recovery in the US fails to provide enough jobs momentum a return of QE some time in Q3 may be a possibility. In Asia, the critical question is China, as losses on investments continue to accumulate and eventually need to be realised.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/saxobank/53812/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Rebuilding Together is providing free critical home repairs to eligible homeowners affected by Superstorm Sandy through our affiliates in New York City, Long Island, Bergen County, Jersey City, and Essex County. As of October 2013, these affiliates have brought together over 3,150 volunteers to complete work on more than 250 projects that assist more than 430 people.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60143-rebuilding-together-web-series-rebuilding-after-sandy
According to the U.S. Census Bureau, more than 34.6 million adults ages 18 and above do not have a high school diploma. In an effort to combat this critical issue, the Ad Council and the Dollar General Literacy Foundation joined today to launch new public service advertisements (PSAs) on behalf of their national GED Achievement campaign. This multimedia campaign is designed to provide high school dropouts the encouragement and information needed to begin the road to a GED diploma.
Recent data shows that students who drop out of high school tend to earn less and have a lower quality of life. Many of them must work multiple jobs just to support their family. Moreover, as of 2009, nearly 30% of adults with household incomes at or below the federal poverty line did not have a high school credential.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55571-ad-council-dollar-general-literacy-foundation-your-ged-pep-talks-psa
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Royal Philips Electronics (NYSE: PHG, AEX: PHI) today introduced the HomeLox portable liquid oxygen system. The innovative system enables oxygen users to generate and store the liquid form of oxygen in the home setting. The HomeLox system offers users the long-lasting and lightweight characteristics of traditional liquid systems, while freeing them from difficulties of filling and dependence on deliveries associated with conventional systems.
Home oxygen is a critical, life-sustaining medical treatment prescribed to nearly 1.5 million Medicare patients annually who suffer from respiratory illnesses such as chronic obstructive pulmonary disease (COPD).
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/philips/45648/
According to a recent national survey, 17.1 percent of Americans lack health insurance, and more than nine million of the nation’s uninsured rely on federally qualified health centers (FQHC), non-profit community clinics and free clinics each year for primary care. While these clinics serve the critical health care needs of the uninsured, patients oftentimes cannot afford the medications prescribed by the clinic’s physicians, or navigate a fragmented system that only offers partial solutions. This is a particularly growing problem for America’s working poor.
Today, Medco Foundation and Dispensary of Hope (DOH), a not-for-profit pharmacy-focused social venture for the uninsured, introduced a new, national initiative to substantially improve the supply, delivery and management of critical prescription drugs to thousands of uninsured Americans who are managing a chronic illness.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54424-medco-dispensary-of-hope-prescription-drug-program-clinics-uninsured
While Dubai’s glam fans celebrated the best local fashion offerings at Fashion Forward Dubai (March 31-April 2), the Pepsi® lounge offered a sophisticated set-up for fashionistas to chill out in amongst the chic goings-on of the three day style fest. Guests of the pop-up lounge enjoyed a selection of delectable Pepsi®-inspired street-style dining delights, including ice-cold Pepsi®, hot eats and cool treats such as Pepsi®-flavored ice cream creations.
“Fashion Forward Dubai is a very important event for us,” said Hossam Dabbous, Vice President, Beverages Category, PepsiCo, Middle East and North Africa. “It’s an event that we are proud to have a continued sponsorship of, as it enables us to provide support to the region’s up and coming creative talent. Dubai, and the GCC in general, is home to some incredible talents, especially in the field of fashion. Being able to provide them with a platform that emphasizes their capabilities is critical to helping them to achieve the success they deserve. The Pepsi lounge at Fashion Forward Dubai echoed the sophisticated glamor of the event in true Pepsi style, bringing together chic design with fun, familiar and refreshing flavor.”
Pepsi® has sponsored Fashion Forward Dubai since 2013.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7819951-pepsi-glam-lounge-fashion-forward-dubai/
Palo Alto Networks® (NYSE: PANW), the next-generation security company, today announced the latest edition of its Application Usage and Threat Report (AUTR) completed by the Palo Alto Networks Unit 42 Threat Intelligence team.
The report, based on data from more than 7,000 enterprises worldwide, showcases real-world trends in enterprise application usage and critical developments in how attackers are attempting to infect organizations. It also offers practical recommendations for preventing cyberattacks.
Findings highlight the explosion in adoption of software as a service (SaaS) based applications, with the potential to introduce new security risks, or allow unauthorized access to sensitive data. Through the report, security organizations also gain insight into how long-standing and common attack vectors, such as email and executable files, continue to present challenges, as well as global application usage trends for high-risk categories, such as remote access applications.
To view the multimedia release go to:
http://www.multivu.com/players/English/7049352-palo-alto-networks-autr/
In response to the devastation wrought by Hurricane Sandy, the Ad Council launched today a new series of television, print and Web public service advertisements (PSAs) encouraging Americans to help by making financial contributions to charitable relief organizations. Monetary donations enable relief organizations to react with speed and specificity across all critical sectors, for both immediate relief and long-term recovery operations, providing the most urgently needed supplies and services to those affected by the storm.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59002-ad-council-hurricane-sandy-and-disaster-relief-coalition
OptiNose US Inc. today announced results of a study testing delivery of the migraine medicine sumatriptan with a novel device using OptiNose breath powered Bi-Directional™ nasal technology. In a direct comparison of drug absorption, the study found that OptiNose's sumatriptan product sent 62% more drug into the blood in the critical first 15 minutes than Imitrex® nasal spray (AUC 0-15 = 1.69 ng*hr/mL and 1.04 ng*hr/mL, respectively). The OptiNose technology achieved this improved effect despite delivering 20% less drug into the nose (16mg) than the Imitrex® liquid nasal spray (20mg).
To view Multimedia News Release, go to http://www.multivu.com/players/English/57713-optinose-innovative-breath-powered-nasal-delivery-technology-delivers-drugs-to-treat-variety-of-medical-conditions
